참고문헌
- Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010;115:168-186. https://doi.org/10.1182/blood-2009-06-225565
- Font J, Lopez-Soto A, Cervera R, et al. The 'primary' antiphospholipid syndrome: antiphospholipid antibody pattern and clinical features of a series of 23 patients. Autoimmunity 1991;9:69-75. https://doi.org/10.3109/08916939108997126
- Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306. https://doi.org/10.1111/j.1538-7836.2006.01753.x
- Udayakumar N, Ezhilan N, Rajendiran C. Primary antiphospholipid antibody syndrome: how certain can you be of the diagnosis? J Clin Rheumatol 2007;13:53. https://doi.org/10.1097/01.rhu.0000255750.71659.64
- Ballerini G, Gemmati D, Moratelli S, Morelli P, Serino ML. Anticardiolipin antibody-related thrombocytopenia: persistent remission after splenectomy. Haematologica 1995;80:248-251.
- Diz-Kucukkaya R, Hacihanefioglu A, Yenerel M, et al. Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study. Blood 2001;98:1760-1764. https://doi.org/10.1182/blood.V98.6.1760
- Bidot CJ, Jy W, Horstman LL, Ahn ER, Yaniz M, Ahn YS. Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS). Am J Hematol 2006;81:391-396. https://doi.org/10.1002/ajh.20571
- Arfors L, Winiarski J, Lefvert AK. Prevalence of antibodies to cardiolipin in chronic ITP and reactivity with platelet membranes. Eur J Haematol 1996;56:230-234.
- Font J, Cervera R, Lopez-Soto A, et al. Anticardiolipin antibodies in patients with autoimmune diseases: isotype distribution and clinical associations. Clin Rheumatol 1989;8:475-483. https://doi.org/10.1007/BF02032099
- Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009;114:937-951. https://doi.org/10.1182/blood-2009-03-209262
- Stasi R, Stipa E, Masi M, et al. Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura. Blood 1994;84:4203-4208.
- Kaburaki J, Kuwana M, Ikeda Y. Anti-cardiolipin-beta2-GPI complex antibodies in idiopathic thrombocytopenic purpura. Intern Med 1998;37:796.
- Pierrot-Deseilligny Despujol C, Michel M, khellaf m, et al. Antiphospholipid antibodies in adults with immune thrombocytopenic purpura. Br J Haematol 2008;142:638-643. https://doi.org/10.1111/j.1365-2141.2008.07228.x
- George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996;88:3-40.
- Page H. New criteria for diagnosing SLE. JAMA 1982;248:622. https://doi.org/10.1001/jama.1982.03330060004002
- Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
- Pengo V, Tripodi A, Reber G, et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/ Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2009;7:1737-1740. https://doi.org/10.1111/j.1538-7836.2009.03555.x
- Hughes GR. The anticardiolipin syndrome. Clin Exp Rheumatol 1985;3:285-286.
피인용 문헌
- Association between the valine/leucine247 polymorphism of β2-glycoprotein I and susceptibility to anti-phospholipid syndrome: a meta-analysis vol.21, pp.8, 2011, https://doi.org/10.1177/0961203312440348
- The immunopathogenesis of immune thrombocytopenia: T cells still take center-stage vol.19, pp.5, 2011, https://doi.org/10.1097/moh.0b013e3283567541
- The Challenge of Bleeding in Antiphospholipid Antibody-Positive Patients vol.17, pp.2, 2011, https://doi.org/10.1007/s11926-014-0481-0
- Refractory Immunological Thrombocytopenia Purpura and Splenectomy in Pregnancy vol.2015, pp.None, 2015, https://doi.org/10.1155/2015/216362
- Current treatment of antiphospholipid syndrome: lights and shadows vol.11, pp.10, 2011, https://doi.org/10.1038/nrrheum.2015.88
- A Seeming Paradox : Ischemic Stroke in the Context of Idiopathic Thrombocytopenic Purpura vol.22, pp.2, 2016, https://doi.org/10.1177/1076029614545213
- Thromboembolism in patients with immune thrombocytopenia (ITP): a meta-analysis of observational studies vol.103, pp.6, 2011, https://doi.org/10.1007/s12185-016-1974-6
- IgG/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis vol.14, pp.8, 2011, https://doi.org/10.1111/jth.13379
- Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta‐analysis vol.97, pp.4, 2011, https://doi.org/10.1111/ejh.12777
- Incidence of Antiphospholipid Antibodies in Patients With Immune Thrombocytopenia and Correlation With Treatment With Steroids in North Indian Population vol.23, pp.6, 2011, https://doi.org/10.1177/1076029616643820
- Cardiovascular and bleeding outcomes in a population‐based cohort of patients with chronic immune thrombocytopenia vol.17, pp.6, 2011, https://doi.org/10.1111/jth.14446
- Multifocal avascular necrosis in a patient with refractory immune thrombocytopenia and antiphospholipid antibodies; case report and review of literature vol.30, pp.5, 2011, https://doi.org/10.1080/09537104.2018.1535701
- Potential therapeutics for antiphospholipid antibody associated thrombocytopenia: A systematic review and meta-analysis vol.30, pp.1, 2011, https://doi.org/10.1080/14397595.2018.1558934
- Update on diagnosis and treatment of immune thrombocytopenia vol.14, pp.5, 2021, https://doi.org/10.1080/17512433.2021.1903315